AICAR (50 mg Vial)

AICAR (50 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
AICAR (50 mg Vial)

Synonyms/Alias: AICAR

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

AICAR (50 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water → ~ 16.7 mg/mL concentration.

Research dosing range: 1,000–3,000 mcg once daily (conservative gradual approach).

Easy measuring: At 16.7 mg/mL, 1 unit = 0.01 mL ≈ 167 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 4 weeks; avoid freeze–thaw cycles.

Notes

Practical considerations for research protocols. Use new sterile insulin syringes for each injection; dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation [11]. Inject slowly; wait a few seconds before withdrawing the needle. Document daily dose, administration time, and site rotation for consistency. AICAR is prohibited by WADA and not approved for human therapeutic use [1].

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Weeks 1–2
Daily Dose: 1,000 mcg (1 mg) | Units (per injection) (mL): 6 units (0.06 mL)
Weeks 3–4
Daily Dose: 2,000 mcg (2 mg) | Units (per injection) (mL): 12 units (0.12 mL)
Weeks 5–8
Daily Dose: 3,000 mcg (3 mg) | Units (per injection) (mL): 18 units (0.18 mL)
Long-term Storage Conditions
Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 4 weeks; avoid freeze–thaw cycles.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (AICAR, 50 mg each): 8 weeks (gradual 1–3 mg/day) ≈ 3 vials

12 weeks (2–5 mg/day advanced) ≈ 8 vials

Insulin Syringes (U-100, or 30/50-unit for precision): Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle

12 weeks (8 vials): 24 mL → 3 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China

Related Products

Related Services